AUG 25, 2016 3:03 PM PDT

Hopkins Opens First Multidisciplinary Center Focused on Zika

WRITTEN BY: Xuan Pham
It seems that Zika cases are increasing daily. But amid this public health crisis, researchers are discovering new insight into the disease almost weekly. Now the Johns Hopkins Hospital is responding to this crisis by opening the first ever multidisciplinary Zika center. The goal is to have a central place where patients can get comprehensive care, while also giving researchers the best access and resources to develop therapies, faster.

Zika was a relatively an unknown name in the Americas until around 2015 when the outbreak in Brazil caught the world’s attention. Now it’s part of the common household news, especially for some residents in Florida where cases of locally transmitted viruses were confirmed.

The Zika virus is known to cause microcephaly, a birth defect that affects the brain. As such, pregnant women are the highest at-risk group. Compounding the problem is that Zika was found to be sexually transmitted. One of the latest report about Zika shows that this virus can also cause eye abnormalities in more than half of babies with the illness.

As Zika cases continue to grow worldwide and within the United States, many organizations are ramping up efforts to contain this disease. For example, Florida, the first state to have confirmed local transmission, is strengthening their insecticide tactics to curb the spread of Zika-infected mosquitos to other areas. Meanwhile, the National Institute of Health recently launched the first clinical trial of a Zika vaccine.

As for Hopkins, they hope to tackle both patient care and research simultaneously. Because of the link of Zika to eye abnormalities, Hopkins’ Zika center will be part of the Wilmer Eye Institute. In addition, the center will also collaborate with experts in epidemiology, infectious disease, maternal-fetal medicine, ophthalmology, and pediatrics.

"Patients will no longer be required to travel to multiple centers for care relating to the Zika virus," said Dr. William May, associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. "Physicians and staff members in various departments at Johns Hopkins will be available to provide comprehensive care to patients within one institution."
 

"It's an ideal set-up for pregnant women exposed to Zika," said Dr. Jeanne S. Sheffield, director of the Hopkins' Division of Maternal-Fetal Medicine. "We have people who can do initial evaluations, people in pediatrics, ophthalmologists and others who can consult and follow-up with kids. This set-up allows us to communicate about anyone who comes in and tests positive."

In the US, over 2,200 cases of Zika have been diagnosed. Of this, 529 are pregnant women. It is not yet known how many babies have been born with microcephaly, as not all babies born to Zika-infected mothers are affected. A centralized location could allow scientists to collect extensive and valuable data on Zika, identify trends, and rapidly discover new treatment options.
 
Additional source: Baltimore Sun
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 16, 2019
Health & Medicine
JUL 16, 2019
Can Scientists Create a Blood Test to Screen for Alzheimer's Risk?
Currently, to gauge the risk of Alzheimer’s disease, patients must undergo brain scans, spinal fluid tests, or mental assessments; all of which can b...
AUG 23, 2019
Immunology
AUG 23, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
SEP 26, 2019
Clinical & Molecular DX
SEP 26, 2019
The Invisible Killers in Your Home
Do you know a mist of air freshener or the burning of a deliciously-scented candle in your home is a "sweet" and a slow poison to you and your loved ones....
OCT 24, 2019
Clinical & Molecular DX
OCT 24, 2019
Patients can Self-Inject Easily Using an Integrated Pre-Filled Syringe and Autoinjector
The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. To prevent a monthly visit...
NOV 05, 2019
Cannabis Sciences
NOV 05, 2019
Single Exposure to CBD & THC Disrupts Embryonic Development
It only takes one incidence of cannabinoid exposure during the first month of pregnancy to yield detrimental effects on a developing embryo. New research r...
JAN 04, 2020
Immunology
JAN 04, 2020
Why Do Skincare Products Sometimes Cause Rashes?
Chemicals commonly found in skincare products are intended to avoid interactions with the part of the immune system responsible for triggering allergic inf...
Loading Comments...